Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of Pseudomonas aeruginosa
Rosario Menéndez, Raúl Méndez, Isabel Amara‐Elori, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2631-2631
Open Access | Times Cited: 25

Showing 25 citing articles:

Inflammatory Molecular Endotypes in Bronchiectasis: A European Multicenter Cohort Study
Hayoung Choi, Soorack Ryu, Holly R. Keir, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 11, pp. 1166-1176
Closed Access | Times Cited: 28
Pathogenesis of Extraarticular Manifestations in Rheumatoid Arthritis—A Comprehensive Review
Joško Mitrović, Stela Hrkač, Josip Tečer, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1262-1262
Open Access | Times Cited: 26
Rethinking bronchiectasis as an inflammatory disease
Merete Long, Sanjay H. Chotirmall, Michal Shteinberg, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 11, pp. 901-914
Closed Access | Times Cited: 12
Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and therapies
Céline Vidaillac, Sanjay H. Chotirmall
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 5, pp. 649-662
Closed Access | Times Cited: 42
Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention
Hayoung Choi, James D. Chalmers
Annals of Translational Medicine (2022) Vol. 11, Iss. 1, pp. 25-25
Open Access | Times Cited: 25
Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity
Xuejie Wang, Carmen Villa, Yadira Dobarganes, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 16, pp. 8431-8431
Open Access | Times Cited: 30
Establishment and characterization of persistent Pseudomonas aeruginosa infections in air–liquid interface cultures of human airway epithelial cells
Safaa Bouheraoua, Sven Cleeves, Matthias Preuße, et al.
Infection and Immunity (2025)
Open Access
Virulence factors of Pseudomonas aeruginosa and immune response during exacerbations and stable phase in bronchiectasis
Roberto Cabrera, Nona Rovira-Ribalta, Ana Motos, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis
Giulia Scioscia, Victoria Alcaraz-Serrano, Raúl Méndez, et al.
Archivos de Bronconeumología (2022) Vol. 58, Iss. 11, pp. 773-775
Closed Access | Times Cited: 18
Association between non-cystic fibrosis bronchiectasis and the risk of incident dementia: A nationwide cohort study
Sang Hyuk Kim, Kyungdo Han, Jongkyu Park, et al.
Chronic Respiratory Disease (2023) Vol. 20
Open Access | Times Cited: 10
Risk Factors and Relation with Mortality of a New Acquisition and Persistence of Pseudomonas aeruginosa in COPD Patients
Miguel Ángel Martínez‐García, Rosa Faner, Grace Oscullo, et al.
COPD Journal of Chronic Obstructive Pulmonary Disease (2021) Vol. 18, Iss. 3, pp. 333-340
Open Access | Times Cited: 19
Future Directions in Bronchiectasis Research
Rosanel Amaro, Lídia Perea, Oriol Sibila
Clinics in Chest Medicine (2022) Vol. 43, Iss. 1, pp. 179-187
Closed Access | Times Cited: 12
Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan
Chun‐Yu Lin, Hung-Yu Huang, Meng‐Heng Hsieh, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 10
Cardiovascular Events During and After Bronchiectasis Exacerbations and Long-term Mortality
Raúl Méndez, Laura Feced, Victoria Alcaraz-Serrano, et al.
CHEST Journal (2021) Vol. 161, Iss. 3, pp. 629-636
Closed Access | Times Cited: 13
Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review
Riccardo Inchingolo, Chiara Pierandrei, Giuliano Montemurro, et al.
Antibiotics (2021) Vol. 10, Iss. 3, pp. 326-326
Open Access | Times Cited: 11
Management erwachsener Patientinnen und Patienten mit Bronchiektasen-Erkrankung
Felix C. Ringshausen, Ingo Baumann, A de Roux, et al.
Pneumologie (2024) Vol. 78, Iss. 11, pp. 833-899
Open Access | Times Cited: 1
Do Redox Balance and Inflammatory Events Take Place in Mild Bronchiectasis? A Hint to Clinical Implications
Liyun Qin, María Guitart, Mireia Admetlló, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 19, pp. 4534-4534
Open Access | Times Cited: 10
Pseudomonas aeruginosa in Bronchiectasis
Laia Fernández‐Barat, Victoria Alcaraz-Serrano, Rosanel Amaro, et al.
Seminars in Respiratory and Critical Care Medicine (2021) Vol. 42, Iss. 04, pp. 587-594
Closed Access | Times Cited: 8
Bronchiectasis Exacerbations: Definitions, Causes, and Acute Management
Sivan Perl, Michal Shteinberg
Seminars in Respiratory and Critical Care Medicine (2021) Vol. 42, Iss. 04, pp. 595-605
Closed Access | Times Cited: 7
Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study
Xuejie Wang, Carmen Villa, Yadira Dobarganes, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 225-225
Open Access | Times Cited: 4
Is bronchiectasis associated with cardiovascular disease?
Miguel Ángel Martínez‐García, Amina Bekki, Thais Beaupertuy, et al.
Respiratory Medicine and Research (2022) Vol. 81, pp. 100912-100912
Closed Access | Times Cited: 4
The effect of N-acetylcysteine in patients with non-cystic fibrosis bronchiectasis (NINCFB): study protocol for a multicentre, double-blind, randomised, placebo-controlled trial
Yue Liao, Yanqiu Wu, Kai Zi, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
IL-6 and TIMP-1 Correlated to Airway Pathogen Colonization and Predict Disease Severity in Patients with Non-Cystic Fibrosis Bronchiectasis
Horng‐Chyuan Lin, Meng‐Heng Hsieh, Yu‐Lun Lo, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5701-5709
Open Access
The Association Between Systemic Immune-Inflammation Index at Admission and Readmission in Patients with Bronchiectasis
Fei Gao, Siqi He, Jing Li, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 6051-6061
Open Access
Isolation of and risk factors for airway infection with Pseudomonas aeruginosa in patients with non-cystic fibrosis bronchiectasis
Mara Rúbia Fernandes de Figueiredo, Isabella Lomonaco, Amanda Souza Araújo, et al.
Jornal Brasileiro de Pneumologia (2021), pp. e20210017-e20210017
Open Access | Times Cited: 3
Page 1

Scroll to top